# GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

> **NCT07747805** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 30 (estimated)

## Conditions studied

- COPD
- Obesity & Overweight
- Sarcopenia

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07747805
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-28
- **Primary completion:** 2028-08-15
- **Final completion:** 2029-08-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07747805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07747805, "GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07747805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*